FDA Investigator Sangeeta M Rataul
Sangeeta M Rataul has conducted inspections on 2 sites in 2 countries as of 19 Jun 2008. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
19 Jun 2008
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
India,
United States of America
FDA Investigators that have inspected at least one site in common with Sangeeta M Rataul:
Abby E Pelletier,
Alexander M Kay,
Anita Narula, PhD,
Ann L Demarco,
Arsen Karapetyan,
Ashar P Parikh,
Astrida B Mattson,
Barbara Janine Breithaupt,
Bradley Dworak, PhD,
Caryn M Mcnab,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Connie P Rezendes,
Cynthia J Lee, MS,
Dawn E Barkans,
Debra I Love,
Dolores E Price,
Don H Bark, PhD,
Dr. Barbara D Paul, PhD,
Edwin Melendez,
Eileen A Liu,
Gerard Pde Leon,
Gloria J Baca, MS,
Heika R Bounds,
Heika R Tait,
Jacqueline Mdiaz Albertini,
Jennifer L Bridgewater,
Joey V Quitania,
Justin A Boyd,
Kari M Johansen,
Kathryn A Krentz,
Kenneth O Gee, PhD,
Kevin P Foley,
Kristin M Abaonza,
Laurel A Beer,
LCDR Debra Emerson,
Lisa K Capron,
Lucila B Nwatu,
Lynda L Perry, PhD,
Maria Pkelly Doggett, MBA,
Marijo B Kambere, PhD,
Mariza M Jafary,
Mark W Babbitt,
Matthew B Casale,
Maxine H Wong,
Mihaly S Ligmond,
Mikel T Wright,
Narong Chamkasem, PhD,
Neil J Bonzagni, PhD MPH,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Randy L Self,
Rebecca Rodriguez,
Rita K Kabaso,
Rita K Vick,
Robert D Tollefsen,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Stephen D Brown,
Steven P Donald,
Susan F Laska, MS,
Terri L Dodds,
Thomas J Arista,
Tina S Roecklein,
Tonia F Bernard,
Torrance J Slayton,
Tracy K Li,
Unnee Ranjan,
Uttaniti Limchumroon (Tom),
Vilmary Negron Rodriguez,
Xiomara Copeland,
Yasamin Ameri
Sangeeta M Rataul's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2008 | FDA 483 Response | Jubilant HollisterStier LLC - Form 483R, 2008-08-25 |
July, 2008 | FDA 483 | Jubilant HollisterStier LLC - Form 483, 2008-07-02 |
December, 2006 | FDA 483 | Intas Pharmaceuticals Limited - Form 483, 2006-12-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more